Strategies in the prevention and control of the COVID-19 pandemic caused by SARS-CoV-2. Environmental factors
e202011115
Keywords:
COVID-19, SARS-CoV-2, Influenza, Flu, Environmental factors, Temperature, Humidity, Ultraviolet light, Seasons of the year, Particulate matterAbstract
The role that environmental factors can play in preventing and controlling the COVID-19 epidemic was explored and compared to that of influenza. Papers cited by the U.S. National Academy of Sciences were discussed, which indicate that temperature and humidity in the environment can influence the intensity of the spread of the disease. The fact that influenza viruses and coronaviruses appeared seasonally, prevailing in the winter and declining in the summer, was illustrated. It was discussed that ultraviolet light in the environment can contribute to the control of the spread of the virus. A study was cited to suggest that particulate matter contributes to increased infection mortality, and that it increases in summer in some regions, countering the health effects of humidity and temperature. Data generated by online electronic tools was compared with surveillance reports generated by the U.S. Centers for Disease Control and Prevention. The epidemic began stronger in northern hemisphere countries during the northern winter. (Evidence that the epidemic intensified during the southern winter is not disputed.) The incidence declined in the northern hemisphere during the summer, except for the U.S., where cases doubled. Evidence suggests that the high degree of SARS-CoV-2 infection counteracts the role that environmental factors may play in COVID-19 control.
Downloads
References
Rhodes JM, Subramanian S, Laird E, Kenny RA. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Aliment. Pharmacol. Ther. 2020; 51(12):1434-1437. https://doi.org/10.1111/apt.15777
Worldometer. Coronavirus: Casos reportados y muertes por país, territorio o transporte. 2020; Disponible en: https://bit.ly/2Tg2sVB
Centers for Disease Control and Prevention. Enfermedad del coronavirus 2019 (COVID-19). Cómo protegerse y proteger a los demás. 2020; Disponible en:
He D, Gao D, Li Y, Zhuang Z, Cao P, Lou Y et al. An Updated Comparison of COVID-19 and Influenza. SSRN Elec J 2020. https://doi.org/10.2139/ssrn.3573503
Shao N, Cheng J, ChenW. The reproductive number R0 of COVID-19 based on estimate of a statistical time delay dynamical system. medRxiv 2020:2020.02.17.20023747. https://doi.org/10.1101/2020.02.17.20023747
Ke R, Sanche S, Romero-Severson E, Hengartner N. Fast spread of COVID-19 in Europe and the US suggests the necessity of early, strong and comprehensive interventions. 2020. https://doi.org/10.1101/2020.04.04.20050427
Centers for Disease Control and Prevention. Carga de la enfermedad de la influenza. Centers for Disease Control and Prevention 2019; Disponible en: https://bit.ly/3a31oKn
Centers for Disease Control and Prevention. Estudios de los CDC sobre la efectividad de la vacuna contra la influenza estacional. Centers for Disease Control and Prevention 2019; Disponible en: https://bit.ly/3coqaGv
Reed C, Chaves SS, Daily Kirley P, Emerson R, Aragon D, Hancock EB et al. Estimating influenza disease burden from population-based surveillance data in the United States. PLoS One 2015; 10(3):e0118369.
https://doi.org/10.1371/journal.pone.0118369
Centers for Disease Control and Prevention. Porciento de muertes causadas por influenza, pulmonía y COVID-19 Centers for Disease Control and Prevention 2020; Disponible en: https://bit.ly/2yENCAX
Food and Drug Administration. Actualización sobre el coronavirus (COVID-19): La FDA emite una autorización de uso de emergencia para el posible tratamiento con COVID-19. Food and Drug Administration 2020; Disponible en: https://bit.ly/2y9XVN1
Food and Drug Administration. Recomendaciones para el plasma convaleciente de investigación COVID-19. Food and Drug Administration 2020; Disponible en:
Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J et al. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial. JAMA 2020. https://doi.org/10.1001/jama.2020.10044
Dowdy D, D’Souza G. Early Herd Immunity against COVID-19: A Dangerous Misconception. 2020; Disponible en: https://bit.ly/2X4jabD
The National Academies of Sciences, E., and Medicine, Rapid Expert Consultation on SARS-CoV-2 Survival in Relation to Temperature and Humidity and Potential for Seasonality for the COVID-19 Pandemic (April 7, 2020). 2020, Washington, DC: The National Academies of Sciences, Engineering, and Medicine. The National Academies Press. 8. https://doi.org/10.17226/25771
Notari A. Temperature dependence of COVID-19 transmission. 2020. https://doi.org/10.1101/2020.03.26.20044529
Sajadi MM, Habibzadeh P, Vintzileos A, Shokouhi S, Miralles-Wilhelm F, Amoroso A. Temperature and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19. SSRN Elec J 2020.
https://doi.org/10.2139/ssrn.3550308
Islam N, Shabnam S, Erzurumluoglu AM. Temperature, humidity, and wind speed are associated with lower Covid-19 incidence. 2020.
https://doi.org/10.1101/2020.03.27.20045658
Ficetola GF, Rubolini D. Climate affects global patterns of COVID-19 early outbreak dynamics. 2020.
https://doi.org/10.1101/2020.03.23.20040501
Wang J, Tang K, Feng K, Lv W. High Temperature and High Humidity Reduce the Transmission of COVID-19. SSRN Elec J 2020. https://doi.org/10.2139/ssrn.3551767
van Doremalen N, Bushmaker T, Munster VJ. Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill. 2013; 18(38).
https://doi.org/10.2807/1560-7917.es2013.18.38.20590
Chan KH, Peiris JS, Lam SY, Poon L, Yuen KY, Seto WH. The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus. Adv. Virol. 2011; 2011:734690. https://doi.org/10.1155/2011/734690
Steel J, Palese P, Lowen AC. Transmission of a 2009 pandemic influenza virus shows a sensitivity to temperature and humidity similar to that of an H3N2 seasonal strain. J Virol 2011; 85(3):1400-2.
https://doi.org/10.1128/JVI.02186-10
Qi H, Xiao S, Shi R, Ward MP, Chen Y, Tu W et al. COVID-19 transmission in Mainland China is associated with temperature and humidity: A time-series analysis. Sci. Total Environ. 2020; 728:138778.
https://doi.org/10.1016/j.scitotenv.2020.138778
Luo W, Majumder MS, Liu D, Poirier C, Mandl KD, Lipsitch M et al. The role of absolute humidity on transmission rates of the COVID-19 outbreak. 2020.
https://doi.org/10.1101/2020.02.12.20022467
World Health Organization. Influenza Laboratory Surveillance Information generated on 11/08/2020 16:57:19 UTC by the Global Influenza Surveillance and Response System (GISRS) Northern hemishere. 2020; Disponible en:
World Health Organization. Influenza Laboratory Surveillance Information generated on 11/08/2020 17:11:35 UTC by the Global Influenza Surveillance and Response System (GISRS) Southern hemisphere. 2020.
Blanton L, Kniss K, Smith S, Mustaquim D, Steffens C, Flannery B et al. Update: Influenza Activity-United States and Worldwide, May 24–September 5, 2015. MMWR 2015; 64(36):1011-1016.
https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6436a4.htm
Centers for Disease Control and Prevention. About Severe Acute Respiratory Syndrome (SARS). Centers for Disease Control and Prevention 2013 04/09/2020]; Disponible en: https://www.cdc.gov/sars/guidance/core/app1.pdf
Ahmed SF, Quadeer AA, McKay MR. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Viruses 2020; 12(3).
https://doi.org/10.3390/v12030254
Forster P, Forster L, Renfrew C, Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc. Natl. Acad. Sci. U. S. A. 2020; 117(17):9241-9243.
https://doi.org/10.1073/pnas.2004999117
Lan L, Xu D, Ye G, Xia C, Wang S, Li Y et al. Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA 2020.
https://doi.org/10.1001/jama.2020.2783
Xiao AT, Tong YX, Zhang S. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence. J Med Virol 2020.
https://doi.org/10.1002/jmv.25855
Sagripanti JL, Lytle CD. Inactivation of influenza virus by solar radiation. Photochem. Photobiol. 2007; 83(5):1278-82. https://doi.org/10.1111/j.1751-1097.2007.00177.x
Ratnesar-Shumate S, Williams G, Green B, Krause M, Holland B, Wood S et al. Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces. J Infect Dis 2020; 222(2):214-222. https://doi.org/10.1093/infdis/jiaa274
Schuit M, Ratnesar-Shumate S, Yolitz J, Williams G, Weaver W, Green B et al. Airborne SARS-CoV-2 is Rapidly Inactivated by Simulated Sunlight. J Infect Dis 2020. https://doi.org/10.1093/infdis/jiaa334
Dowell SF. Seasonal variation in host susceptibility and cycles of certain infectious diseases. Emerg Infect Dis 2001; 7(3):369-74. https://doi.org/10.3201/eid0703.010301
Panarese A, Shahini E. Letter: Covid-19, and vitamin D. Aliment. Pharmacol. Ther. 2020; 51(10):993-995. https://doi.org/10.1111/apt.15752
Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017; 356:i6583. https://doi.org/10.1136/bmj.i6583
Wu X, Nethery, RC, Sabath BM, Braun D, Dominici F. Exposure to air pollution and COVID-19 mortality in the United States: A nationwide cross-sectional study. medRxiv 2020:2020.04.05.20054502.
https://www.ncbi.nlm.nih.gov/pubmed/32511651
Chen R, Peng RD, Meng X, Zhou Z, Chen B, Kan H. Seasonal variation in the acute effect of particulate air pollution on mortality in the China Air Pollution and Health Effects Study (CAPES). Sci. Total Environ. 2013; 450-451:259-65. https://doi.org/10.1016/j.scitotenv.2013.02.040
Peng RD, Dominici F, Pastor-Barriuso R, Zeger SL, Samet JM. Seasonal analyses of air pollution and mortality in 100 US cities. Am. J. Epidemiol. 2005; 161(6):585-94. https://doi.org/10.1093/aje/kwi075
Ortiz JR, Zhou H, Shay DK, Neuzil KM, Fowlkes AL, Goss CH. Monitoring influenza activity in the United States: a comparison of traditional surveillance systems with Google Flu Trends. PLoS One 2011; 6(4):e18687. https://doi.org/10.1371/journal.pone.0018687
Olson DR, Konty KJ, Paladini M, Viboud C, Simonsen L. Reassessing Google Flu Trends data for detection of seasonal and pandemic influenza: a comparative epidemiological study at three geographic scales. PLoS Comput Biol 2013; 9(10):e1003256.
https://doi.org/10.1371/journal.pcbi.1003256
Moisse K. “Google Flu Trends” Found to Be Nearly on Par with CDC Surveillance Data. Sci. Am. 2010; Disponible en: https://bit.ly/3bdITEs
Lazer D, Kennedy R, King G, Vespignani A. Big data. The parable of Google Flu: traps in big data analysis. Science 2014; 343(6176):1203-5.
https://doi.org/10.1126/science.1248506
Kinsa US. Healthweather Map. 2020 April 15, 2020]; Disponible en: https://healthweather.us/
Insights K. HealthWeather by Kinsa Insights - The amount of current unexpected illness, expressed as additional share of the population affected by influenza-like illness, above the expected values.; 10 de agosto de 2020. 2020; Disponible en: https://bit.ly/3kAwboh
Centers for Disease Control and Prevention. NCHS Mortality Surveillance Data Data as of August 6, 2020 for the Week Ending August1, 2020 (Week 31). Centers for Disease Control and Prevention 2020; Disponible en: https://bit.ly/3gUnDXd
Puerto Rico Health Department. Informe influenza - Semana 18. Sistema de Vigilancia de Influenza de Puerto Rico 2020; Disponible en: https://bit.ly/3bA8gQ8
Puerto Rico Health Department. Coronavirus. 2020; Disponible en: https://bit.ly/2WEbzS0
Centers for Disease Control and Prevention. Weekly U.S. Influenza Surveillance Report: Key Updates for Week 16, ending April 18, 2020. Centers for Disease Control and Prevention 2020; Disponible en: https://bit.ly/3c53XgV
Gaunt ER, Hardie A, Claas EC, Simmonds P, and Templeton KE. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol 2010; 48(8):2940-7. https://doi.org/10.1128/JCM.00636-10
Tendencias de Google. Comparación de con . 2020 3 de mayo de 2020]; Disponible en: https://bit.ly/3abH1uo
Centers for Disease Control and Prevention. National Syndromic Surveillance Program (NSSP): Emergency Department Visits Percentage of Visits for COVID-19-Like Illness (CLI) or Influenza-like Illness (ILI) September 29, 2019 - April 4, 2020 Data as of April 9, 2020. Centers for Disease Control and Prevention 2020 1 de mayo de 2020]; Disponible en: https://bit.ly/2KS2gY9
Centers for Disease Control and Prevention. 2020. Casos, datos y vigilancia. Datos anteriores de casos de COVID-19 en los EEUU. Disponible en:
https://espanol.cdc.gov/coronavirus/2019-ncov/cases-updates/previouscases.html.
Yao Y, Pan J, Liu Z, Meng X, Wang W, Kan H et al. No association of COVID-19 transmission with temperature or UV radiation in Chinese cities. Eur. Respir. J. 2020; 55(5).
https://doi.org/10.1183/13993003.00517-2020
Yao M, Zhang L, Ma J, Zhou L. On airborne transmission and control of SARS-Cov-2. Sci. Total Environ. 2020:139178.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Francisco Alberto Tomei Torres
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
